| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $693K | -98.4% |
| Cost of Revenue | $104K | -99.5% |
| Gross Profit | $589K | -97.4% |
| R&D Expense | $3.7M | -88.2% |
| SG&A Expense | $8.4M | -59.2% |
| Operating Income | -$11.6M | +63.1% |
| Pre-tax Income | -$8.4M | +71.0% |
| Income Tax | -$184K | -138.5% |
| Net Income | -$22.5M | +21.7% |
| EPS (Basic) | -$4.08 | -732.7% |
| EPS (Diluted) | -$4.08 | -732.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.2M | -52.5% |
| Current Assets | $50.2M | +44.1% |
| Total Assets | $51.3M | -20.0% |
| Current Liabilities | $20.0M | +139.9% |
| Total Liabilities | $20.9M | -13.8% |
| Stockholders' Equity | -$21.1M | -99.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$20.6M | -4.0% |
| Capital Expenditures | $448K | -88.1% |
| Investing Cash Flow | $3.3M | +206.0% |
| Financing Cash Flow | $11.7M | +1307.0% |
| Free Cash Flow | -$21.1M | +10.7% |